Please Wait.....
Report
Bovine Mastitis Market By Product (Antibiotics, Other), By Route of administration (Intramammary, Systemic), By Application (Veterinary Hospitals and Clinics, On-site Treatment): Global Opportunity Analysis and Industry Forecast, 2021-2031
Market Report I 2022-09-01 I 300 Pages I Allied Market Research
The global bovine mastitis market was valued at $0.54 billion in2021 and is projected to reach $1,006.44 million by 2031, registering a CAGR of 6.3% from 2022 to 2031.
Bovine mastitis is an inflammatory response of the udder tissue in the mammary gland brought on by microbial infections or physical damage. It is regarded as the most prevalent illness that causes financial loss in the dairy sector as a result of decreased output and poor milk quality.
The increase in the number of incidences of bovine mastitis and the rise in infectious diseases in animals boost the growth of the market. For instance, according to an article published in 2020, by IntechOpen, a leading global publisher of Journals and Books within the fields of Science, Technology, and Medicine, the overall prevalence of subclinical mastitis in cows was 31.55%. The prevalence of subclinical mastitis was highest in the 5-7 years of age group (38.50%). Thus, the surge in bovine mastitis and associated infectious diseases drive the growth of the market.
Furthermore, the increase in awareness about bovine mastitis and the rise in concern for veterinary care contribute to the growth of the market. Bovine mastitis can be treated with antibiotics such as erythromycin and tylosin. It can be prevented by maintaining good hygiene, use of properly functioning milking machines; maintaining clean, dry, & comfortable housing areas; segregation & culling of persistently infected animals, and dry cow antibiotic therapy.
In addition, factors such as growth in demand for dairy products and a rise in the number of milking animals such as cows and buffalos propel the growth of the market. For instance, according to the survey of McKinsey & Company, a global management consulting firm, in 2020, compared with pre-pandemic levels, there was a 163 % increase in U.S. dairy consumers who report shopping for dairy mostly online. Thus, the rise in demand for dairy products contributes to the growth of the market.
Moreover, the increase in R&D activities for the development of advanced bovine mastitis treatment, and the rise in U.S. food and drug administration (FDA) approvals. and novel product launch in the market by key players boost the market growth. For instance, in February 2020, Ecolab Inc., the global leader in water, food safety, and health technologies and services, introduced Eco-Flex Teat Dip, an effective and affordable udder care solution for dairy cows that helps prevent infection, improve teat health, and support milk quality. Furthermore, advancements in bovine mastitis such as the integration of artificial intelligence (AI) based tools for the assessment of cow's health further contribute to market growth. However, the antibiotic resistance in cattle and lack of awareness about bovine mastitis countries may hinder the growth of the market. Due to repeated use of antibiotics, bacteria and fungi develop the ability to defeat the drugs designed to kill them, this phenomenon is called antibiotic resistance.
The bovine mastitis market is segmented on the basis of product, route of administration, end-user, and region. By product, the market is divided into antibiotics and others. Depending on the route of administration, the market is classified into intramammary and systemic. By end user, the market is categorized into veterinary hospitals & clinics, and on-site treatment,. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include Armenta Ltd., Boehringer Ingelheim GmbH, Ecolab Inc., Forte Healthcare Ltd., Huvepharma NV, Merck KGaA, Mileutis Ltd, Neogen Corporation, Thermo Fisher Scientific Inc., and Zoetis Inc.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the bovine mastitis market analysis from 2021 to 2031 to identify the prevailing bovine mastitis market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
-An in-depth analysis of the bovine mastitis market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global bovine mastitis market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Antibiotics
- Other
By Route of administration
- Intramammary
- Systemic
By Application
- Veterinary Hospitals and Clinics
- Cases
- Mild Cases
- Moderate Cased
- Severe Cases
- On-site Treatment
- Cases
- Mild Cases
- Moderate Cases
- Severe Cases
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- UK
- Italy
- Spain
- Rest Of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest Of Asia-Pacific
- LAMEA
- Brazil
- Turkey
- Rest Of LAMEA
- Key Market Players
- Armenta Ltd.
- Boehringer Ingelheim Gmbh
- Ecolab Inc.
- Forte Healthcare Ltd.
- Huvepharma nv
- Merck KGaA
- Mileutis Ltd
- Neogen Corporation
- Thermo Fisher Scientific Inc
- Zoetis Inc.
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: BOVINE MASTITIS MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Antibiotics
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Other
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Intramammary
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Systemic
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: BOVINE MASTITIS MARKET, BY APPLICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Veterinary Hospitals and Clinics
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.2.4 Veterinary Hospitals and Clinics Bovine Mastitis Market by Cases
6.2.4.1 Mild Cases Market size and forecast, by region
6.2.4.2 Moderate Cased Market size and forecast, by region
6.2.4.3 Severe Cases Market size and forecast, by region
6.3 On-site Treatment
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.3.4 On-site Treatment Bovine Mastitis Market by Cases
6.3.4.1 Mild Cases Market size and forecast, by region
6.3.4.2 Moderate Cases Market size and forecast, by region
6.3.4.3 Severe Cases Market size and forecast, by region
CHAPTER 7: BOVINE MASTITIS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.3 North America Market size and forecast, by Route of administration
7.2.4 North America Market size and forecast, by Application
7.2.4.1 North America Veterinary Hospitals and Clinics Bovine Mastitis Market by Cases
7.2.4.2 North America On-site Treatment Bovine Mastitis Market by Cases
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product
7.2.5.1.2 Market size and forecast, by Route of administration
7.2.5.1.3 Market size and forecast, by Application
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product
7.2.5.2.2 Market size and forecast, by Route of administration
7.2.5.2.3 Market size and forecast, by Application
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product
7.2.5.3.2 Market size and forecast, by Route of administration
7.2.5.3.3 Market size and forecast, by Application
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.3 Europe Market size and forecast, by Route of administration
7.3.4 Europe Market size and forecast, by Application
7.3.4.1 Europe Veterinary Hospitals and Clinics Bovine Mastitis Market by Cases
7.3.4.2 Europe On-site Treatment Bovine Mastitis Market by Cases
7.3.5 Europe Market size and forecast, by country
7.3.5.1 France
7.3.5.1.1 Market size and forecast, by Product
7.3.5.1.2 Market size and forecast, by Route of administration
7.3.5.1.3 Market size and forecast, by Application
7.3.5.2 Germany
7.3.5.2.1 Market size and forecast, by Product
7.3.5.2.2 Market size and forecast, by Route of administration
7.3.5.2.3 Market size and forecast, by Application
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Product
7.3.5.3.2 Market size and forecast, by Route of administration
7.3.5.3.3 Market size and forecast, by Application
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product
7.3.5.4.2 Market size and forecast, by Route of administration
7.3.5.4.3 Market size and forecast, by Application
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product
7.3.5.5.2 Market size and forecast, by Route of administration
7.3.5.5.3 Market size and forecast, by Application
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product
7.3.5.6.2 Market size and forecast, by Route of administration
7.3.5.6.3 Market size and forecast, by Application
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.3 Asia-Pacific Market size and forecast, by Route of administration
7.4.4 Asia-Pacific Market size and forecast, by Application
7.4.4.1 Asia-Pacific Veterinary Hospitals and Clinics Bovine Mastitis Market by Cases
7.4.4.2 Asia-Pacific On-site Treatment Bovine Mastitis Market by Cases
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Product
7.4.5.1.2 Market size and forecast, by Route of administration
7.4.5.1.3 Market size and forecast, by Application
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Product
7.4.5.2.2 Market size and forecast, by Route of administration
7.4.5.2.3 Market size and forecast, by Application
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Product
7.4.5.3.2 Market size and forecast, by Route of administration
7.4.5.3.3 Market size and forecast, by Application
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Product
7.4.5.4.2 Market size and forecast, by Route of administration
7.4.5.4.3 Market size and forecast, by Application
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Product
7.4.5.5.2 Market size and forecast, by Route of administration
7.4.5.5.3 Market size and forecast, by Application
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Product
7.4.5.6.2 Market size and forecast, by Route of administration
7.4.5.6.3 Market size and forecast, by Application
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.3 LAMEA Market size and forecast, by Route of administration
7.5.4 LAMEA Market size and forecast, by Application
7.5.4.1 LAMEA Veterinary Hospitals and Clinics Bovine Mastitis Market by Cases
7.5.4.2 LAMEA On-site Treatment Bovine Mastitis Market by Cases
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product
7.5.5.1.2 Market size and forecast, by Route of administration
7.5.5.1.3 Market size and forecast, by Application
7.5.5.2 Turkey
7.5.5.2.1 Market size and forecast, by Product
7.5.5.2.2 Market size and forecast, by Route of administration
7.5.5.2.3 Market size and forecast, by Application
7.5.5.3 Rest of LAMEA
7.5.5.3.1 Market size and forecast, by Product
7.5.5.3.2 Market size and forecast, by Route of administration
7.5.5.3.3 Market size and forecast, by Application
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Armenta Ltd.
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Boehringer Ingelheim Gmbh
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Ecolab Inc.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Forte Healthcare Ltd.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Huvepharma nv
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Merck KGaA
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Mileutis Ltd
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Neogen Corporation
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Thermo Fisher Scientific Inc
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Zoetis Inc.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 2. BOVINE MASTITIS MARKET, FOR ANTIBIOTICS, BY REGION, 2021-2031 ($MILLION)
TABLE 3. BOVINE MASTITIS MARKET FOR ANTIBIOTICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. BOVINE MASTITIS MARKET, FOR OTHER, BY REGION, 2021-2031 ($MILLION)
TABLE 5. BOVINE MASTITIS MARKET FOR OTHER, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. GLOBAL BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 7. BOVINE MASTITIS MARKET, FOR INTRAMAMMARY, BY REGION, 2021-2031 ($MILLION)
TABLE 8. BOVINE MASTITIS MARKET FOR INTRAMAMMARY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 9. BOVINE MASTITIS MARKET, FOR SYSTEMIC, BY REGION, 2021-2031 ($MILLION)
TABLE 10. BOVINE MASTITIS MARKET FOR SYSTEMIC, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 11. GLOBAL BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 12. BOVINE MASTITIS MARKET, FOR VETERINARY HOSPITALS AND CLINICS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. BOVINE MASTITIS MARKET FOR VETERINARY HOSPITALS AND CLINICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 14. GLOBAL VETERINARY HOSPITALS AND CLINICS BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 15. BOVINE MASTITIS MARKET, FOR MILD CASES, BY REGION, 2021-2031 ($MILLION)
TABLE 16. BOVINE MASTITIS MARKET, FOR MODERATE CASED, BY REGION, 2021-2031 ($MILLION)
TABLE 17. BOVINE MASTITIS MARKET, FOR SEVERE CASES, BY REGION, 2021-2031 ($MILLION)
TABLE 18. BOVINE MASTITIS MARKET, FOR ON-SITE TREATMENT, BY REGION, 2021-2031 ($MILLION)
TABLE 19. BOVINE MASTITIS MARKET FOR ON-SITE TREATMENT, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 20. GLOBAL ON-SITE TREATMENT BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 21. BOVINE MASTITIS MARKET, FOR MILD CASES, BY REGION, 2021-2031 ($MILLION)
TABLE 22. BOVINE MASTITIS MARKET, FOR MODERATE CASES, BY REGION, 2021-2031 ($MILLION)
TABLE 23. BOVINE MASTITIS MARKET, FOR SEVERE CASES, BY REGION, 2021-2031 ($MILLION)
TABLE 24. BOVINE MASTITIS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 25. NORTH AMERICA BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 26. NORTH AMERICA BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 27. NORTH AMERICA BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 28. NORTH AMERICA VETERINARY HOSPITALS AND CLINICS BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 29. NORTH AMERICA ON-SITE TREATMENT BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 30. NORTH AMERICA BOVINE MASTITIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 31. U.S. BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 32. U.S. BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 33. U.S. BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 34. CANADA BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 35. CANADA BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 36. CANADA BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 37. MEXICO BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 38. MEXICO BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 39. MEXICO BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 40. EUROPE BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 41. EUROPE BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 42. EUROPE BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 43. EUROPE VETERINARY HOSPITALS AND CLINICS BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 44. EUROPE ON-SITE TREATMENT BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 45. EUROPE BOVINE MASTITIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 46. FRANCE BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 47. FRANCE BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 48. FRANCE BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 49. GERMANY BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 50. GERMANY BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 51. GERMANY BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 52. UK BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 53. UK BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 54. UK BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 55. ITALY BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 56. ITALY BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 57. ITALY BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 58. SPAIN BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 59. SPAIN BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 60. SPAIN BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 61. REST OF EUROPE BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 62. REST OF EUROPE BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 63. REST OF EUROPE BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 64. ASIA-PACIFIC BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 65. ASIA-PACIFIC BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 66. ASIA-PACIFIC BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC VETERINARY HOSPITALS AND CLINICS BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 68. ASIA-PACIFIC ON-SITE TREATMENT BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 69. ASIA-PACIFIC BOVINE MASTITIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 70. JAPAN BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 71. JAPAN BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 72. JAPAN BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 73. CHINA BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 74. CHINA BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 75. CHINA BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 76. INDIA BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 77. INDIA BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 78. INDIA BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 79. AUSTRALIA BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 80. AUSTRALIA BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 81. AUSTRALIA BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 82. SOUTH KOREA BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 83. SOUTH KOREA BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 84. SOUTH KOREA BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 85. REST OF ASIA-PACIFIC BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 86. REST OF ASIA-PACIFIC BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 87. REST OF ASIA-PACIFIC BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 88. LAMEA BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 89. LAMEA BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 90. LAMEA BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 91. LAMEA VETERINARY HOSPITALS AND CLINICS BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 92. LAMEA ON-SITE TREATMENT BOVINE MASTITIS MARKET, BY CASES, 2021-2031 ($MILLION)
TABLE 93. LAMEA BOVINE MASTITIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 94. BRAZIL BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 95. BRAZIL BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 96. BRAZIL BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 97. TURKEY BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 98. TURKEY BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 99. TURKEY BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 100. REST OF LAMEA BOVINE MASTITIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 101. REST OF LAMEA BOVINE MASTITIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2031 ($MILLION)
TABLE 102. REST OF LAMEA BOVINE MASTITIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 103.ARMENTA LTD.: COMPANY SNAPSHOT
TABLE 104.ARMENTA LTD.: OPERATING SEGMENTS
TABLE 105.ARMENTA LTD.: PRODUCT PORTFOLIO
TABLE 106.ARMENTA LTD.: NET SALES,
TABLE 107.ARMENTA LTD.: KEY STRATERGIES
TABLE 108.BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT
TABLE 109.BOEHRINGER INGELHEIM GMBH: OPERATING SEGMENTS
TABLE 110.BOEHRINGER INGELHEIM GMBH: PRODUCT PORTFOLIO
TABLE 111.BOEHRINGER INGELHEIM GMBH: NET SALES,
TABLE 112.BOEHRINGER INGELHEIM GMBH: KEY STRATERGIES
TABLE 113.ECOLAB INC.: COMPANY SNAPSHOT
TABLE 114.ECOLAB INC.: OPERATING SEGMENTS
TABLE 115.ECOLAB INC.: PRODUCT PORTFOLIO
TABLE 116.ECOLAB INC.: NET SALES,
TABLE 117.ECOLAB INC.: KEY STRATERGIES
TABLE 118.FORTE HEALTHCARE LTD.: COMPANY SNAPSHOT
TABLE 119.FORTE HEALTHCARE LTD.: OPERATING SEGMENTS
TABLE 120.FORTE HEALTHCARE LTD.: PRODUCT PORTFOLIO
TABLE 121.FORTE HEALTHCARE LTD.: NET SALES,
TABLE 122.FORTE HEALTHCARE LTD.: KEY STRATERGIES
TABLE 123.HUVEPHARMA NV: COMPANY SNAPSHOT
TABLE 124.HUVEPHARMA NV: OPERATING SEGMENTS
TABLE 125.HUVEPHARMA NV: PRODUCT PORTFOLIO
TABLE 126.HUVEPHARMA NV: NET SALES,
TABLE 127.HUVEPHARMA NV: KEY STRATERGIES
TABLE 128.MERCK KGAA: COMPANY SNAPSHOT
TABLE 129.MERCK KGAA: OPERATING SEGMENTS
TABLE 130.MERCK KGAA: PRODUCT PORTFOLIO
TABLE 131.MERCK KGAA: NET SALES,
TABLE 132.MERCK KGAA: KEY STRATERGIES
TABLE 133.MILEUTIS LTD: COMPANY SNAPSHOT
TABLE 134.MILEUTIS LTD: OPERATING SEGMENTS
TABLE 135.MILEUTIS LTD: PRODUCT PORTFOLIO
TABLE 136.MILEUTIS LTD: NET SALES,
TABLE 137.MILEUTIS LTD: KEY STRATERGIES
TABLE 138.NEOGEN CORPORATION: COMPANY SNAPSHOT
TABLE 139.NEOGEN CORPORATION: OPERATING SEGMENTS
TABLE 140.NEOGEN CORPORATION: PRODUCT PORTFOLIO
TABLE 141.NEOGEN CORPORATION: NET SALES,
TABLE 142.NEOGEN CORPORATION: KEY STRATERGIES
TABLE 143.THERMO FISHER SCIENTIFIC INC: COMPANY SNAPSHOT
TABLE 144.THERMO FISHER SCIENTIFIC INC: OPERATING SEGMENTS
TABLE 145.THERMO FISHER SCIENTIFIC INC: PRODUCT PORTFOLIO
TABLE 146.THERMO FISHER SCIENTIFIC INC: NET SALES,
TABLE 147.THERMO FISHER SCIENTIFIC INC: KEY STRATERGIES
TABLE 148.ZOETIS INC.: COMPANY SNAPSHOT
TABLE 149.ZOETIS INC.: OPERATING SEGMENTS
TABLE 150.ZOETIS INC.: PRODUCT PORTFOLIO
TABLE 151.ZOETIS INC.: NET SALES,
TABLE 152.ZOETIS INC.: KEY STRATERGIES
LIST OF FIGURES
FIGURE 1.BOVINE MASTITIS MARKET SEGMENTATION
FIGURE 2.BOVINE MASTITIS MARKET,2021-2031
FIGURE 3.BOVINE MASTITIS MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.BOVINE MASTITIS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.BOVINE MASTITIS MARKET,BY PRODUCT,2021(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ANTIBIOTICS BOVINE MASTITIS MARKET,2021-2031(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF OTHER BOVINE MASTITIS MARKET,2021-2031(%)
FIGURE 15.BOVINE MASTITIS MARKET,BY ROUTE OF ADMINISTRATION,2021(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF INTRAMAMMARY BOVINE MASTITIS MARKET,2021-2031(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF SYSTEMIC BOVINE MASTITIS MARKET,2021-2031(%)
FIGURE 18.BOVINE MASTITIS MARKET,BY APPLICATION,2021(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF VETERINARY HOSPITALS AND CLINICS BOVINE MASTITIS MARKET,2021-2031(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF ON-SITE TREATMENT BOVINE MASTITIS MARKET,2021-2031(%)
FIGURE 21.BOVINE MASTITIS MARKET BY REGION,2021
FIGURE 22.U.S. BOVINE MASTITIS MARKET,2021-2031($MILLION)
FIGURE 23.CANADA BOVINE MASTITIS MARKET,2021-2031($MILLION)
FIGURE 24.MEXICO BOVINE MASTITIS MARKET,2021-2031($MILLION)
FIGURE 25.FRANCE BOVINE MASTITIS MARKET,2021-2031($MILLION)
FIGURE 26.GERMANY BOVINE MASTITIS MARKET,2021-2031($MILLION)
FIGURE 27.UK BOVINE MASTITIS MARKET,2021-2031($MILLION)
FIGURE 28.ITALY BOVINE MASTITIS MARKET,2021-2031($MILLION)
FIGURE 29.SPAIN BOVINE MASTITIS MARKET,2021-2031($MILLION)
FIGURE 30.REST OF EUROPE BOVINE MASTITIS MARKET,2021-2031($MILLION)
FIGURE 31.JAPAN BOVINE MASTITIS MARKET,2021-2031($MILLION)
FIGURE 32.CHINA BOVINE MASTITIS MARKET,2021-2031($MILLION)
FIGURE 33.INDIA BOVINE MASTITIS MARKET,2021-2031($MILLION)
FIGURE 34.AUSTRALIA BOVINE MASTITIS MARKET,2021-2031($MILLION)
FIGURE 35.SOUTH KOREA BOVINE MASTITIS MARKET,2021-2031($MILLION)
FIGURE 36.REST OF ASIA-PACIFIC BOVINE MASTITIS MARKET,2021-2031($MILLION)
FIGURE 37.BRAZIL BOVINE MASTITIS MARKET,2021-2031($MILLION)
FIGURE 38.TURKEY BOVINE MASTITIS MARKET,2021-2031($MILLION)
FIGURE 39.REST OF LAMEA BOVINE MASTITIS MARKET,2021-2031($MILLION)
FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 43.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 44.COMPETITIVE DASHBOARD
FIGURE 45.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 46.ARMENTA LTD..: NET SALES ,($MILLION)
FIGURE 47.BOEHRINGER INGELHEIM GMBH.: NET SALES ,($MILLION)
FIGURE 48.ECOLAB INC..: NET SALES ,($MILLION)
FIGURE 49.FORTE HEALTHCARE LTD..: NET SALES ,($MILLION)
FIGURE 50.HUVEPHARMA NV.: NET SALES ,($MILLION)
FIGURE 51.MERCK KGAA.: NET SALES ,($MILLION)
FIGURE 52.MILEUTIS LTD.: NET SALES ,($MILLION)
FIGURE 53.NEOGEN CORPORATION.: NET SALES ,($MILLION)
FIGURE 54.THERMO FISHER SCIENTIFIC INC.: NET SALES ,($MILLION)
FIGURE 55.ZOETIS INC..: NET SALES ,($MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security